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Abstract 
The total membrane concentrations ofPtdIns, PtdIns4P, and PtdIns(4,5)P, contribute to the functional capacity of the Ins(1,4,5)Pj signalling system 
which is operating in skeletal muscle but the function of which is still unknown. Total amounts of these phosphoinositides have been determined 
in purified membranes of transverse tubules (lT) and terminal cistemae (TC) of the sarcoplasmic reticulum (SR) of rabbit skeletal muscle. PtdIns 
and PtdIns4P have been detected in both membrane systems whereas PtdIns(4,5)P, (290 pol/mol phospholipid) is confined only to ‘FT. A much 
greater pool of PtdIns(4,5)P, seems, however, to be located in the sarcolemma way from the triadic junction. 
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1. IntruduetIon 
The concept that inositol 1,4,5-triphosphate (Ins- 
(1,4,5)PJ acts as an intracellular chemical transmitter in 
the fast excitation-contraction coupling process of skele- 
tal muscle has been put forward by several groups [l-3]. 
There are, however, severe objections to this idea which 
have been worked out in detail by [4]. A second concept 
favours a messenger action of Ins(1,4,5)P, on a larger 
time scale aiming at the excitation-contraction coupling 
mechanism and/or the energy metabolism of the skeletal 
muscle fibre [5]. A key event of the Ins( 1,4,5)P,-signalling 
pathway is the cleavage of Ins(1,4,5)P, from phosphati- 
dylinositol4,5-biphosphate (PtdIns(4,5)Pb by phospho- 
lipase C (PLC) [6] that has to fit in quite different time 
frames depending on which of the concepts is realised in 
skeletal muscle. It is well established that the activity of 
skeletal muscle PLC is strongly regulated by myoplasmic 
Ca2+ in a concentration range that is reached during 
muscle activation [7,8]. Up to now it is unknown whether 
this Ca2’-sensitivity, which is common to all known PLC 
isoforms [9], represents the primary event for PLC-acti- 
vation or whether a different membrane borne process 
switches on the enzyme Ca2+-independently. A putative 
assignment of the activation mechanism to one of the 
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established classes (G protein activated for PLC-B; re- 
ceptor tyrosine kinase activated for PLC-y [6,9]) is not 
possible because a PLC isoform of skeletal muscle has 
not yet been identitied by protein or cDNA sequencing. 
There is, however, evidence that two PLC, i.e. a cytosolic 
and a membrane associated form, coexist in skeletal 
muscle [7,8] and that the myoplasmic enzyme might be 
different from the known PLC families [lo]. The mem- 
brane associated enzyme is localised mainly at the TT 
[7,8]. Membranes of the SR seem either to be devoid of 
this enzyme [7] or contain marginal PLC activity [8]. 
Compared to the knowledge accumulated on skeletal 
muscle PLC only little is known about membrane local- 
isation and content of its substrate, PtdIns(4,5)P,. In the 
present work we have studied in detail the total concen- 
tration and localisation of phosphatidylinositol (Ptdlns), 
phosphatidylinositol4-phosphate (PtdI&P), and PtdIns- 
(4,5)P, in TT membranes and in membranes of the TC 
of the SR which come in close apposition at the level of 
triads (for review see [l 11). The data provide information 
on the capacity and limitations of the Ins(1,4,5)P, sig- 
nalling system in skeletal muscle focused on the 
phosphoinositides in the different membrane systems. 
Preliminary results of the work have been presented in 
abstract form [12]. 
2. Materials and methods 
2.1. Preparation of purified triads, m and TC 
Skeletal muscle microsomes and triads were isolated from rabbit 
back muscle according to [ 131. The pellet resulting from the 6nal centrif- 
ugation at 100,000 x g was homogenised in 250 mM sucrose, 3 mM 
his&line, pH 7.3, and centrifuged at 70,000 x g overnight on a linear 
sucrose density gradient (15-50% w/w sucrose). The gradient was frac- 
tionated and the fractions (1.5 ml) were assayed for dihydropyridine 
binding according to [14] using 0.5 nM [‘H]PN200/110 and for ryan- 
odine binding according to [ 15] employing 1.5 nM [‘H]ryanodine. The 
distribution of the SR Ca’+ transport ATPase activity was monitored 
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by measuring the dephosphorylation of 4-methylumbelliferyl phos- 
phate (MUM) in the fractions according to [16]. The phospholipid 
content of the fractions was determined by combining phospholipid 
extraction [171 and determination of organic phosphorus [181. Aliquots 
of the fractions (20 ul) were mixed with 500 ~1 chloroform/methanol 
(4: 1, v/v), 33 ~12.4 ‘N’HCl, and 30 ~1 H,O and stirred vigorously for 
1 min. After brief centrifugation, the organic phases were transferred 
to phosphate-free glass tubes and their phospholipid phosphorus con- 
tents were determined as described below. Protein was determined with 
the bicinchoninic acid method [19] using bovine serum albumin as 
standard. Certain gradient fractions which contained puri6ed triads 
(see section 3) were pooled and subjected to French press treatment 
according to 1201. The pressure treated purified triads were separated 
by isopy&c sucrose density centrifugation and fractionated as de- 
scribed above. The distribution of protein and phospholipid and like- 
wise of ryanodine binding and PNZbo/l 10 binding in-the gradients was 
determined as described before. Fractions that contained only one 
defined membrane type (i.e. purified ‘IT or purified TC, see section 3) 
were pooled. 
2.2. Extraction and deacylation of phospholipids 
Character&d membrane fractions were subjected to a two-step lipid 
extraction procedure according to [17]. Purified triads (5-20 mg) pmi- 
fied TT (l-7 mg), and purified TC (l-7 mg), respectively, were ex- 
tracted with 5 volumes of chloroform/methanol (4: 1, v/v) and 0.67 
volumes of 2.4 N HCl. After vortexing for 1 min and brief centrifuga- 
tion, the lower organic phases were carefully removed and transferred 
to other glass tubes. These samples were further extracted with one 
volume of 2.4 N HCYmethanol (1: 1, v/v) and the organic phases were 
again transferred quantitatively to new glass vials. The organic phases 
were evaporated to dryness in a speedvac and the dried lipid extracts 
were redissolved in 200 ~1 chloroform. The recovery of the lipid extrac- 
tion procedure was determined by adding [3H]PtdIns4P and 
[31-IlPtdIns(4,5)P, (both 1.5 x 10’ Bq/ml), respectively, to the purified 
membranes and measuring the radioactivity regained in the final chlo- 
roform phase by scintillation counting. For both phosphoinositides, the 
obtained recoveries were in the range of 90 to 96% of the initially 
employed radioactivity. Analysis of these chloroform phases by one- 
dimensional high-performance thin-layer chromatography, HPTLC 
(see below), revealed a single spot in both cases, indicating that no 
significant dephosphorylation of phosphoinositides occurs during the 
lipid extraction procedure. An aliquot of the chloroform phases ob- 
tained from the purified membranes was used for the determination of 
PtdIns by HPTLC (see below). The remains of these lipid extracts were 
deacylated according to the method of [21]. The chloroform phase was 
mixed with 1 ml monomethylamine r agent (2596, v/v) and incubated 
in a sealed glass tube at 53OC for 40 min. Thereafter, 500 ~1 ice-cold 
n-propanol was added and the sample was evaporated to dryness in a 
speedvac. The resulting pellet was redissolved in a mixture of 1 ml H,O 
and 1.2 ml n-butanol/petrolether/ethyl formate (20 : 4 : 1, by volume). 
The aqueous phase, which contains the glycerophosphoinositol-deriva- 
tives of phosphoinositides and other phosphohpids, was quantitatively 
transfer& to another tube and dried in a-speedvac. It was redissolved 
in HPLC samole buffer (2.5 mM sodium acetate, 1 mM NaF, pH 5.0) 
for quantit&e determination of glycerophosphoinositol phdsphates 
by high-performance liquid chromatography (HPLC) with metal-dye 
detection (see below). 
Deacylation of reference compounds, [31-IJPtdIns4P respectively 
[‘H]PtdIns(4,5)P,, according to the described protocol revealed a de- 
acylation efficiency of 8593% of the originally employed phosphoinos- 
itides. Moreover, deacylation of [‘H]PtdIns4P produced only 
[SI-I@oPIns4P and deacylation of [3wPtdIns(4,5)P, yielded only 
[‘H]GroPIns(4,5)P, indicating that no dephosphorylation of phospho- 
inositides occurred during the procedure. 
2.3. Analysis of glycerophosphoinositol phosphates 
The glycerophosphoinositol phosphates resulting from PtdIns4P and 
PtdIns(4,5)P, after deacylation of purified membranes were analysed 
by HPLC with metal-dye detection as described previously [5]. A 
0.5 x 20 cm Mono Q column (Pharmacia, Uppsala, Sweden) with a 
0.5 x 1 cm guard column (Mono Q) was employed with a neutral elu- 
tion system (weak ehtant: 10 mM triethanolamine.HCl, pH 8.0; strong 
eluant: 1 M KCl, 10 mM triethanolamine.HCL, pH 8.0) recommended 
for the quantitative determination of phosphoinositide deacylation 
products [22]. Separated glycerophosphoinositol derivatives were iden- 
tifled and quantified with the aid of calibration runs with the standard 
compounds GroPIns, GroPIns4P and GroPIns(4,5)P,. 
2.4. Determination of Ptdlns by HPTLC 
The PtdIns content of purified triads, TT and TC, respectively, was 
determined by two-dimensional HPTLC employing three solvent sys- 
tems as described by [23]. An aliquot (4 ~1) of the final organic phase 
resulting from the lipid extraction of purified membranes (see above) 
was spotted on a silica gel 60 HPTLC plate. After solvent development, 
lipid spots were visualised by exposing the plates to iodine vapour. In 
narallel exwriments the PtdIns mot was labelled by spiking the purified 
membranes with [‘H]PtdIns (9 ~10~ Bq/ml) prior to the lipid extraction 
procedure described above. It was identified on the plates by autoradi- 
ography before lipid staining and appeared, in agreement with [23], well 
separated from the major phospholipids of the purified membranes, i.e. 
phosphatidylcholine, phosphatidylserine, and phosphatidylethanolam- 
ine, as well as from phosphatidic acid. For quantification of PtdIns in 
an identified spot, the corresponding silica gel was scraped out and 
transferred to a phosphate-free glass tube for phospholipid phosphorus 
determination as described below. The method was calibrated by ana- 
lysing different amounts of PtdIns spotted on the HPILC plates. The 
same standards were also directly applied to tubes and analysed. The 
phosphorus determinations with the scraped out silica gel yielded val- 
ues which were in the order of 95% of those obtained with the latter 
method. 
2.5. One-dimensional HPTLC of [3H]phosphoinositides 
Degradation of ‘H-labelled phosphoinositides during extraction of 
phospholipids and preparation of skeletal muscle microsomes, respec- 
tively, was followed by one-dimensional HPTLC on silica gel 60 
I-IPTLC plates which were previously sprayed with potassium oxalate 
(DH 7.0. 1% v/v in methanol/H,0 (2: 3. v/v)) and dried overnight at 
?OO”C. Ahquots (2-5 ~1) of [‘Hlphosphomositide-labelled phosph&pid 
extracts of purified membranes (see above) and of phospholipid ex- 
tracts of raw muscle homogenates which were initially injected with 
[31-IlPtdIns4P and [3H]PtdIns(4,5)P, (both 1.5 x lti Bq/ml), respec- 
tively, were spotted on the plates. Chloroform/acetone/methanol/lOO% 
acetic acid/H,0 (40: 15 : 13 : 12: 8, by volume) was used as solvent sys- 
tem. After solvent development, ‘H-labelled phosphoinositides were 
visualized by autoradiography and the autoradiograms were quanti6ed 
with the aid of Whole Band Analyzer software on a Bio Image system 
(Millipore, Ann Arbor, MI, USA). 
2.6. Determination ofphospholipid phosphorus 
The phospholipid phosphorus content of chloroform/methanol ex- 
tracts of sucrose gradient fractions as well as of purified triads, TT, and 
TC. resnectivelv. was determined by incineration of the extracts 1181 
followed by ph&phorus determination according to [24]. The extracts 
were evaporated to dryness by centrifugation in a speedvac. The dried 
lipid extracts were incinerated by addition of 100 ~1 10 M H2S04 and 
incubation at 180°C for 1 h. Thereafter, 100 ~1 H202 (33% v/v, phos- 
phate-free) were added and the tubes were again incubated for 1 h at 
18O’C. After cooline down, 50 ul H,O were added and the total volume 
of fluid was determined in each tube. The phosphate content of the 
incinerated material was then determined in aliquots (10 ~1) with a 
speotrophotometric method [24] using microtiter plates. The phospho- 
lipid phosphorus determinations were calibrated by means of phos- 
phate standards treated in the same way as the samples. 
2.7. Materials 
[9,21-“H(N)]ryanodine and (+)-[5-methyl-3H]-PN200/l 10 were from 
NEN DuPont de Nemours (Bad Homburg, Germany). L-3-Phosphat- 
idyl[2-3H]inositol 4-monophosphate and ~~3-phosphatidyl[2-3H]ihosi- 
to1 4,5-bisphosphate were from Amersham (Braunschweig, Germany). 
L-3-phosphatidyl[2-3Hlinositol was from BioTrends (St. Louis, MO, 
USA). Glycerol 3-phosphate, 4-methylumbelliferyl phosphate, 
GroPIns, GroPInsrlP, and GroPIns(4,5)P, were from Boehringer 
(Mannheim, Germany). Silica gel 60 HPTLC plates (10 x 10 cm) were 
from Merck (Darmstadt, Germany). PtdIns, phosphatidylcholme, 
phosphatidylserine, phosphatidylethanohunine, and phosphatidic acid 
were from Sigma (St. Louis, MO, USA). Monomethylamine, petrole- 
ther and triethanolamine were from Fluka (Buchs, Switzerland). HCl 
and n-propanol were from Baker (Deventer, The Netherlands). Ethyl 
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formate and n-butanol were from Riedel de Haen (Se&e, Germany). 
Chemicals and reference compounds used for HPLC analysis were as 
described by [22]. All other chemicals were at least of analytical grade. 
3. Results 
rabbit skeletal muscle microsomes 
linear sucrose gradient (Fig. 
to a protein distribution shown in Fig. la. Part 
of this protein is due to proteins incorporated in or 
ciated 
(Fig. la). 
The distribution 
lowed by high affiity 
(Fig. lb). Fragments 
(Fig. lb). In addition, 
order to identify 
fractions containing parts 1 b). 
In agreement other studies [7,13,20], 
under the MUM phosphatase activity peak at 30% 
sucrose can be assigned 
minor binding of PN200/110 
around 40% sucrose can 
be identified triads [7,13,14]. Those which 
showed substantial 
(Fig. 
1 b, filled symbols) were pooled called purz$ied 
French treatment triads to a 
separation linear 
sucrose gradient (Fig. lc) indicating 
[20]. Fractions which sig- 
nificant ryanodine 
(Fig. lc, filled circles) were pooled 
noted as purzjied TC. Those which showed PN200/110 
binding at the absence of ryanodine binding (Fig. lc, 
filled squares) were pooled and designated as purzjied 
TT. Each of these two pools contained virtually only one 
of the two membrane types existing in skeletal muscle 
triads. They were, together with ptied triads, subjected 
to phospholipid extraction and phosphoinositide analy- 
sis. 
In phospholipid extracts of purified triads, GroPIns4P 
and GroPIns(4,5)P, can be determined and quantified by 
HPLC with metal-dye detection [5,22] after deacylation 
[21] of the extracts (Fig. 2). These glycerophosphoinosi- 
to1 phosphates report the total amounts of PtdIns4P and 
PtdIns(4,5)P2, respectively, in purified triads. The deter- 
mined mean values + S.E. were 2.2 + 0.1 run01 PtdIns4P 
and 0.3 + 0.2 nmol PtdIns(4,5)P, per mg triadic protein. 
The much smaller peak of GroPIns4P compared to 
GroPIns(4,5)P2 reflects the much lower sensitivity of the 
detection method for the former substance [22]. The 
major phospholipids of cell membranes, phosphati- 
dylcholine, phosphatidylserine, and phosphatidyletha- 
nolamine, as well as phosphatidic acid do not lead, after 
processing, to products interfering with the detection of 
GroPIns4P or GroPIns(4,5)P, (Fig. 2 e-h). Their deacyl- 
ation products, glycerophosphocholine, glycero- 
phosphoserine, glycerophosphoethanolamine, and glyc- 
erol 3-phosphate, respectively, together with GroPIns 
(Fig. 2d) which is the deacylation product of PtdIns, 
contribute to the dominant peak detected in purified 
triads (Fig. 2a, assigned with x ). Because of this lack of 
separation of GroPIns from the other deacylation prod- 
ucts of biological membranes and because of the rela- 
tively low sensitivity of the detection method for this 
compound (Fig. 2d), the content of PtdIns in the purified 
skeletal muscle membranes was determined by quantita- 
tive HPTLC (see below). 
GroPIns(4,5)P, was readily detectable and quanttia- 
ble in deacylated phospholipid extracts of purified TT 
(Fig. 3a) whereas it was not detectable in those of puri- 
fied TC (Fig. 3~). On the contrary, GroPIns4P could be 
identified and quantified in both triadic membrane types. 
The determined glycerophosphoinositol phosphates cor- 
respond to total amounts (mean value + S.E.) of 22 f 4 
nmol PtdIns4P and 1.1 + 0.2 nmol PtdIns(4,5)P2 per mg 
protein in TT and to 12 + 3 nmol PtdIns4P per mg pro- 
tein in TC. We have observed that storage of purified TT 
at -70°C prior to phospholipid extraction led to reduced 
total amounts ofGroPlns(4,5)P, compared to immedi- 
ately processed purified TT. For that reason, only data 
obtained from purified membranes processed immedi- 
ately after preparation were considered. Storage of de- 
acylation products of extracted phospholipids in HPLC 
buffer at -70°C did, however, not lead to significant 
decomposition of glycerophosphoinositol phosphates. 
The total content of PtdIns, which is commonly the 
most abundant phosphoinositide in tissues, was deter- 
mined directly by HPTLC of phospholipid extracts of 
purified skeletal muscle membranes (Fig. 4). The spot 
corresponding to PtdIns separated well from those of the 
other phospholipids of these membrane structures. 
Quantification of PtdIns by phospholipid phosphorus 
determination revealed total amounts (mean 
value f S.E.) of 11 f 4 nmol, 141 f 18 mnol, and 
292 f 27 nmol per mg of protein in purified triads, TT, 
and TC, respectively. 
Table 1 compiles the total amounts of PtdIns, 
PtdIns4P, and PtdIns(4,5)P, determined in putied tri- 
ads, TT, and TC. The tabulated values have been cor- 
rected by the mean yield coefficients of the experimental 
procedures that were combined in order to analyse the 
purified membranes (see legend of Table 1). The ob- 
tained data were related to the mass of protein in the 
purified membrane structures that were subjected to 
phosphoinositide analysis as well as to the phospholipid 
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Fig. 1. Separation, identification and purification of triads and triadic membranes prior to phospholipid extraction and analysis. (a, b) Isopycnic 
sucrose density centrifugation of rabbit skeletal muscle microsomes on a linear sucrose gradient. The gradient fractions were scam& for protein 
concentration (a, x), concentration of phospholipid-derived phosphorus (a, *), ryanodine binding (b, q ), PN200/110 binding (b, o), and MUM 
phosphatase activity (b, n). The tilled symbols in b denote those fractions which, according to the actual measurement (corresponding open symbols 
in b), containpurified triads (see text). (c) Separation of pressure cell treated purifled triads by centrifugation on a linear sucrose gradient. The gradient 
fractions were scanned for protein concentration (x), ryanodine binding (o), and PN200/110 binding (0). Fractions containingpurified TTandpuri$ed 
TC are assigned (0) and (m), respectively (see text). 
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PtdIns(4,5)P, (0.7-2.2%). It is obvious that the 
PtdIns(4,5)P, detected in purified triads originates solely 
from TT fragments assembled in this complex super- 
structure. In the purified membrane of TC, only PtdIns 
and PtdIns4P are present. Here, they make up about 19% 
of the total phospholipids and separate into 96% PtdIns 
and 4% PtdIns4P. 
The question whether degradation during membrane 
preparation could have had affected the obtained data 
a- A 
x 
b 
h 
0 IO 20 30 40 
Retention time (min) 
Fig. 2. Identitication of GroPIns4P and GroPIns(4,5)Pr in deacylated 
phospholipid extracts of purified triads by HPLC with metal-dye detec- 
tion. Shown are baseline-subtracted chromatograms of: a, processed 
puriSed triads (5.7 mg); b, GroPIns(4,S)Pr (3.3 mnol); c, GroPIns4P (16 
mnol); d, GroPIns (110 mnol); e, glycerol 3-phosphate (8.3 nmol); 
f, processed phosphatidylcholine (450 mnol); g, processed phosphati- 
dylserine (50 nmol); h, processed phosphatidylethanolamine (50 nmol). 
The peaks assigned y and z in pm&d triads correspond to 24 nmol 
GroPIns4P and 0.8 nmol GroPIns(4,5)P,, respectively. 
content of these membranes approximated by the phos- 
pholipid-derived phosphorus. In purified triads and TT, 
the phosphoinositides eparate to about the same degree 
into PtdIns (80-86%), PtdIns4P (1418%), and 
a 
b 
d 
I 
8 
d 
z i 
0 10 20 30 40 
Retention time (min) 
Fig. 3. Analysis of deacylated phospholipid extracts of purified ‘IT and 
TC by HPLC with metal-dye detection. Shown are baseline-subtracted 
chromatograms of: a, processed purified TT (2 mg); b, mixture of 
GroPIns4P (40 nmol, peak 1) and GroPIns(4,S)Pr (5.8 mnol, peak 2); 
c, processed pm&d TC (1 mg); d, mixture of GroPIns4P (16 mnol, 
peak 1) and GroPIns(4,5)Pr (1.2 nmol, peak 2). In purified IT, the 
peaks assigned y and z correspond to 26 nmol GroPIns4P and 1.5 mnol 
GroPIns(4,5)P, (compared a and b). In puri6ed TC, the peak y corre- 
sponds to 10 nmol GroPIns4P and GroPIns(4,5)P, is not detectable 
(compare c and d). The elution protocol used in a and b was slightly 
different from that used in c and d. 
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Fig. 4. Determination of PtdIns in puritied triads, TT and TC by HPTLC. The chloroform/methanol extracts (4 ~1) of processed purified triads 
(a, 420 pug), ‘PI (b, 60 pg), and TC (c, 140 gg), respectively, were applied on the plates at the spots marked by circles. After solvent development 
the phospholipids were visualized by exposition to iodine vapour. The arrow on each plate indicates the PtdIns spot. The amount of PtdIns in these 
spots obtained by phospholipid phosphorus determination (see section 2) were 9 mnol (a), 19 nmol (b), and 57 mnol (c), respectively. Vertical, 1st 
dimension; horizontal, 2nd dimension. 
was investigated in the following way. [3H]PtdIns4P and 
[3H]PtdIns(4,5)P,, respectively, was added to aliquots of 
the raw muscle homogenate and these samples were incu- 
bated under conditions comparable to the corresponding 
preparative steps. After lipid extraction of the raw homo- 
genate samples, the radioactivity appearing in the or- 
ganic phase was assayed by scintillation counting and 
HPTLC (see section 2). The mean recovery of [3H]inosi- 
to&containing compounds stemming from [3H]PtdIns4P 
and [3H]PtdIns(4,5)Pz was 71.9% and 62.6%, respec- 
tively, which would correspond to a phosphodiesteratic 
cleavage of the initially employed phosphoinositides in 
the raw muscle homogenate by 28.1% and 37.4%, respec- 
tively. According to HPTLC analysis of these lipid ex- 
tracts, the compounds originating from [3H]PtdIns4P 
separated into 91.4% [3H]PtdIns4P and 8.6% [3H]PtdIns 
and those stemming from [3H]PtdIns(4,5)P, into 87.4% 
[3H]PtdIns(4,5)P,, 3.5% [3H]PtdIns4P, and 9.1% 
[3H]PtdIns. Net formation of [3H]PtdIns(4,5)P, from 
[3H]PtdIns4P was not found. These data suggest that 
about 8.6% of the initially employed [3H]PtdIns4P and 
about 12.6% of the initially introduced [3H]PtdIns(4,5)P, 
were degraded by phosphomonoesteratic cleavage in the 
raw muscle homogenate. 
Recently, Ins(1 ,4,5)P3 has been detected in triads of 
rabbit skeletal muscle using a radioreceptor assay [25]. 
For that reason, we have analysed the supematant of 
skeletal muscle microsomes after denaturation with 
trichloroacetic acid by HPLC with dye-detection as de- 
scribed previously [5]. Total amounts of about 5 pmol 
Ins( 1,4,5)P,/mg microsomal protein were detected in 
freshly prepared microsomes which is much less than the 
values reported by [25]. 
4. Discussion 
The general composition of the major phospholipids 
in skeletal muscle SR membranes is fairly well known 
[26-281. There is, however, only very limited knowledge 
about the contents of phosphoinositides in the different 
membrane systems of skeletal muscle especially with re- 
Table 1 
Phosphoinositide content of different rabbit skeletal muscle membranes determined by non-radioactive mass determinations* 
PtdInsb 
(mol/mg protein) (mol/mol 
phospholipid) 
PtdIns4P” 
(mol/mg protein) (mol/mol 
phospholipid) 
PtdIns(4,5)P,C 
(mol/mg protein) (mol/mol 
phospholipid) 
Purified triads 1.2 + 0.4 x lo+ 2.1 + 0.6 x lO-4 (4) 2.7 f 0.1 x lo+ 4.6 + 0.2 x lo-’ (3) 3.4 + 2.5 x 10-l” 5.8 f 4.3 x lo+ (4) 
Puri&ed TT 1.6 ? 0.2 x lO-7 36 + 4 x lo-” (3) 2.6 f 0.5 x lo-* 5.8 f 1.2 x lo+ (5) 1.3 f 0.3 x lo-9 2.9 * 0.7 x lo4 (9) 
Purified TC 3.3 + 0.3 x lo-’ 181 f 17 x 10-r (3) 1.4 + 0.4 x lo-’ 7.5 ? 2.4 x lo-’ (5) not detectable not detectable 
“The values represent mean values ( + S.E.M.) of the number of determinations given in parenthesis. 
bscThe tabulated amounts, N, were derived from the measured total amounts, M, according to N = M/(p x q), where p = 0.93b7c represents the mean 
recovery of phosphoinositides with the lipid extraction procedure, q = 0.95b is the yield coefficient of the phospholipid phosphorus determinations 
in HPTLC spots and q = O.W, respectively, is the mean yield coefficient of phosphoinositides with the phospholipid deacylation procedure (see 
section 2). 
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spect to PtdIns4P and PtdIns(4,5)P, [26-301. Apart from 
skeletal muscle, differential determinations of total mass 
levels of the polyphosphoinositides in subcellular mem- 
branes are generally missing [31]. Our data give a first 
report on the total amounts of phosphoinositides in pre- 
viously characterised subcellular membrane systems 
which are of fundamental importance to muscle function 
[ 111. The results indicate that the phosphoinositide com- 
position of ‘IT membranes is significantly different from 
that of TC membranes. Triadic TT contain all the 
phosphoinositides which establish the complete mem- 
brane localised branche of the Ins( 1,4,5)P, signalling sys- 
tem. In constrast, TC of the SR are devoid of 
PtdIns(4,5)P, and thus lack the capacity of Ins(1,4,5)P, 
generation. A localisation of PtdIns(4,5)P, restricted to 
T-tubular membranes has previously been shown for 
frog skeletal muscle my means of radioisotope tech- 
niques [28] which essentially do not report total mass 
levels. The distribution of phosphoinositides in TT and 
TC membranes, respectively, is in agreement with the 
targeting of enzymes that are involved in the conversion 
of these molecules. PtdIns 4kinase, which catalyses the 
phosphorylation of PtdIns to PtdIns4P, has been found 
in longitudinal SR, TC and ‘PI [7,32]. In contrast, forma- 
tion of PtdIns(4,5)P, from PtdIns4P catalysed by 
PtdIns4P 5-kinase has been detected only in ‘IT [7,32,33]. 
The presence of PtdIns(4,5)P, exclusively in IT could 
thus be due to a specific targeting of PtdIns4P 5-kinase 
to ‘IT membranes. The same seems to apply to a mem- 
brane associated form of PLC which has been detected 
in preparations of TT [7,8] but not in TC membranes [7] 
and only to a little extend in SR membranes [8]. 
In puriGed IT, phosphoinositides represent about 
4.2% of the total phospholipids. This relative content as 
well as the partition of the phosphoinositides into 85.5% 
PtdIns, 13.8% PtdIns4P, and 0.7% PtdIns(4,5)P, is in 
accordance with data obtained from various tissues and 
might be regarded as typical for membranes involved in 
the generation of Ins(1,4,5)P,. The total amount of 
PtdIns relative to the total phospholipid content of puri- 
fied TT obtained in this study is similar to values re- 
ported previously for this membrane of rabbit skeletal 
muscle [29,30]. However, the total phospholipid content 
determined by us is about 3-times higher than the corre- 
sponding values given in these studies [29,30]. This could 
be due to our elaborate procedure for the selection of 
purified membranes which might have led to a higher 
ratio of phospholipid to protein. The total membrane 
concentration of about 290 pmol PtdIns(4,5)P~mol 
phospholipid phosphorus determined in purified ‘IT is 
nearly 5-times the value given in a review [34]. If a sur- 
face area of 60-70 A’ obtained for lecithins in a model 
bilayer [35] is assumed for the phospholipids of the ‘IT 
membrane, a packing density of about 1.5 x lo6 
phospholipids@m* would result. The determined total 
PtdIns(4,5)P, content of ‘IT would then correspond to 
about 435 molecules of PtdIns(4,5)P2/pm2 TT mem- 
brane. In view of the chemical transmitter concept of 
Ins( 1,4,5)P, in excitation-contraction coupling [34] this 
would mean, that the total concentration of the precur- 
sor is in the order of the concentration of the putative 
receptor in mammalian skeletal muscle, the junctional 
feet of the TC membrane (estimated at 340-390&n* of 
total TT surface of red and white leg muscle of guinea 
pig [361). 
The relative phosphoinositide content of the intracel- 
lular TC membrane was significantly higher than that of 
the sarcolemmal TT membrane. The total amount of 
PtdIns relative to the total phospholipid content of puri- 
fied TC is about twice as high as values obtained with 
different SR preparations of rabbit skeletal muscle 
[26,27,29,30]. We have shown previously that PtdIns is 
tightly associated with the Ca*+ transport ATPase of the 
SR and that phosphorylation of this PtdIns activates the 
Ca*+ transport mechanism [371. Part of the relatively 
high PtdIns content could be due to this association for 
Ca*’ transport ATPase is detectable in these membranes 
(see Fig. lb). 
In chicken skeletal muscle cx-actinin represents a high 
capacity binding site for PtdIns(4,5)P, [38]. The purified 
membranes we have investigated contained no a-actinin 
as revealed by inununoblotting with commercially avail- 
able monoclonal antibodies (not shown). The group of 
Hidalgo has recently reported, that surprisingly high 
amounts of Ins(1,4,5)P, in the range of 0.3-0.4 mnol/mg 
protein are present in triads of frog and rabbit skeletal 
muscle [25]. We have determined much lower mass levels 
of about 5 pmol Ins(l,4,5)PJmg microsomal protein 
which corresponds to about 6.7 pmol/mg triadic protein. 
This quantity comes to only 2% of the PtdIns(4,5)P2 
content of purified triads (Table 1). 
The data given in Table 1 could represent lower limits 
of total mass levels of phosphoinositides in puriGed skel- 
etal muscle membranes. If the degradation estimated 
with reference compounds in raw muscle homogenate 
would atfect in the same manner the phosphoinositides 
endogenously present in the skeletal muscle membranes, 
all values given in Table 1 should be multiplied by 1.4 
1.6 in order to compensate the diesteratic leavage. The 
amounts of PtdIns4P and PtdIns(4,5)P2 should further 
be multiplied by 1.1 in order to correct the estimated 
monoesteratic leavage. 
Mass determinations of PtdIns(4,5)P, carried out with 
skeletal muscle microsomes revealed total amounts of 
17-43 nmol PtdIns(4,5)Pdmg microsomal protein which 
correspond to 22-56 nmol PtdIns(4,5)P,lg muscle mass. 
A very similar value of 28 + 11 nmol PtdIns(4,S)PJg wet 
weight has been obtained with a radioisotope method for 
frog skeletal muscle [228]. With the aid of the yield coeffi- 
cients for purified triads (0.97 mg triadic protein/g mus- 
cle mass) and purified TT (0.31 mg TT protein/g muscle 
mass) the total amount of PtdIns(4,5)P, given in 
218 
Table 1 can be extrapolated from the triadic junction to 
the whole cell. The cellular PtdIns(4,5)P, content esti- 
mated in this way is about 0.3-0.4 nmol/g muscle mass 
which is only about 0.5-1X% of the total amount of 
PtdIns(4,5)P, determined with microsomes. These results 
clearly show that overall determinations of phosphoinos- 
itides in whole muscle do not clarify the situation in 
special cellular compartments. They further suggest hat 
the major PtdIns(4,5)P, pool of the sarcolemma is lo- 
cated either in the surface membrane or in the TT away 
from the triadic junction. During tetanic activation of 
skeletal muscle, the total myoplasmic content of inositol 
1,4-biphosphate and Ins(1,4,5)P, increases by about 1.2 
rnnol/g muscle mass on a time scale of seconds [5]. This 
increase would comprise about 2-5% of the estimated 
total mass level of PtdIns(4,5)P, in skeletal muscle and 
could hardly be supplied by the PtdIns(4,5)P, pool of 
triadic TT alone. 
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